Showing results (91-100 of 188) with videos related to

Sort By:
Pageof 19
Cardiovascular and Interventional Radiology|June 26, 1999
Post-traumatic pseudocyst of the spleen: sclerotherapy with ethanolM Völk, G Rogler, M Strotzer, et al.
Journal of Crohn'S & Colitis|April 10, 2013
Topical therapy is underused in patients with ulcerative colitisF Seibold, N Fournier, C Beglinger, et al.
Rofo : Fortschritte Auf Dem Gebiete Der Rontgenstrahlen Und Der Nuklearmedizin|March 27, 2007
[CT-guided percutaneous gastrostomy: success rate, early and late complications]A Gottschalk, M Strotzer, S Feuerbach, et al.
Zeitschrift Fur Gastroenterologie|April 12, 2007
[Surveillance colonoscopy in ulcerative colitis patients in Germany]B Kaltz, B Bokemeyer, J Hoffmann, et al.
FEBS Letters|August 31, 1987
Recombinant human B cell stimulatory factor 2 (BSF-2/IFN-beta 2) regulates beta-fibrinogen and albumin mRNA levels in Fao-9 cellsT Andus, T Geiger, T Hirano, et al.
Clinical and Experimental Immunology|February 1, 1997
Neutralization of tumour necrosis factor (TNF) but not of IL-1 reduces inflammation in chronic dextran sulphate sodium-induced colitis in miceG Kojouharoff, W Hans, F Obermeier, et al.
European Journal of Gastroenterology & Hepatology|June 1, 1996
Distinct patterns of immunoglobulin classes and IgG subclasses of autoantibodies in patients with inflammatory bowel diseaseU Müller-Ladner, V Gross, T Andus, et al.
European Journal of Biochemistry|April 15, 1988
Regulation of synthesis and secretion of major rat acute-phase proteins by recombinant human interleukin-6 (BSF-2/IL-6) in hepatocyte primary culturesT Andus, T Geiger, T Hirano, et al.
European Journal of Immunology|August 1, 1987
Discrimination of hepatocyte-stimulating activity from human recombinant tumor necrosis factor alphaT Andus, P C Heinrich, J Bauer, et al.
Medizinische Klinik (Munich, Germany : 1983)|February 28, 1998
[Cardiovascular and pupillary autonomic and somatosensory neuropathy in chronic diseases with autoimmune phenomena. A comparative study of patients with Crohn disease, ulcerative colitis, systemic lupus erythematosus, progressive systemic sclerosis and type I diabetes mellitus]R H Straub, T Andus, G Lock, et al.
Pageof 19